K. Angela Macfarlane - 10 Mar 2022 Form 4 Insider Report for RenovoRx, Inc. (RNXT)

Role
Director
Signature
K. Angela Macfarlane
Issuer symbol
RNXT
Transactions as of
10 Mar 2022
Net transactions value
$0
Form type
4
Filing time
14 Mar 2022, 16:45:32 UTC
Previous filing
05 Oct 2021
Next filing
04 Oct 2022
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction RNXT Stock option (right to buy) Award $0 -4,582 -50% $0.000000 4,582 10 Mar 2022 Common Stock 4,582 $3.17 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The shares subject to the option vest in twelve equal monthly installments beginning on November 1, 2021.